Kala Bio (KALA) Work In Process (2018 - 2019)
Kala Bio (KALA) reported Work In Process of $6.93 million for Q2 2019, up 62.9% from the prior quarter.
Powered by 
Analysis
Kala Bio (KALA) Work In Process (2018 - 2019) Analysis & Trends
At the end of FY2018, Kala Bio posted Work In Process of $3.36 million.
- Per Business Quant data, the three quarters before Q2 2019 came in at $4.25 million (Q1 2019), $3.36 million (Q4 2018) and $976,000 (Q3 2018).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,224.11 Bn | 1,197.72 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 665.34 Bn | 585.20 Bn | 17.30 Bn |
| 3 | AbbVie | 515.72 Bn | 483.73 Bn | 13.12 Bn |
| 4 | Merck | 362.64 Bn | 325.58 Bn | 13.19 Bn |
| 5 | Novartis Ag | 315.51 Bn | 288.75 Bn | - |
| 6 | Astrazeneca | 289.26 Bn | 263.15 Bn | 13.26 Bn |
| 7 | Amgen | 249.20 Bn | 200.85 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 207.48 Bn | 182.59 Bn | 6.73 Bn |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn |
| 10 | Kala Bio | 2.38 Mn | -42.27 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2019 | 6.93 Mn |
| Mar 31, 2019 | 4.25 Mn |
| Dec 31, 2018 | 3.36 Mn |
| Sep 30, 2018 | 976,000.00 |
API Access
Kala Bio Work In Process API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=work-in-process&ticker=KALA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "work-in-process", "ticker": "KALA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=work-in-process&ticker=KALA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();